FlareTx

YEAR
ALL YEARS
  • 2025
  • 2024
  • 2023
  • 2022
  • All Years
September 8, 2026

Flare Therapeutics Appoints Peter Lebowitz, MD, PhD, to Board of Directors and Brian DeSchuytner as Chief Financial Officer and Chief Business Officer

  Read More
January 9, 2026

Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer

  Read More
January 8, 2026

Flare Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

  Read More
November 25, 2025

Flare Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference

  Read More

Contact Us

Investors

Sarah McCabe
investorrelations@flaretx.com

Media

Timothy Cockroft
media@flaretx.com

CONTACT US | PRIVACY POLICY | TERMS OF USE
© 2026 FLARE THERAPEUTICS INC. ALL RIGHTS RESERVED.
 

This links to an external website.

Continue

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Powered by